← Open Payments lookup

KARLEY MOORE: Open Payments

NPI 1114520491 · MANILA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$393 in 19 payments from 12 companies in 2025. Trend: 2023 $337 · 2024 $398 · 2025 $393

Food & beverage: $393
CompanyPaymentsAmount
Axsome Therapeutics, Inc.3$70
ABBVIE INC.3$67
AstraZeneca Pharmaceuticals LP2$50
Novo Nordisk Inc3$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30
Sumitomo Pharma America, Inc.1$24
Medtronic, Inc.1$22
Otsuka America Pharmaceutical, Inc.1$21
Verona Pharma, Inc.1$21
GlaxoSmithKline, LLC.1$15

Products named: Auvelity, CAPLYTA, Ozempic, FARXIGA, QULIPTA, GEMTESA, AIRSUPRA, VRAYLAR.

Industry payments across AR — which companies pay providers there.